Table 2.
Outcomes.
| 25-gauge PPV | 27-gauge PPV | p value | |
|---|---|---|---|
| N | 37 | 37 | |
| Surgical time, mean ± SD (minutes) | 90.7 ± 29.6 | 86.1 ± 30.1 | 0.5 |
| Anatomical success at month 6, n (%) | 37 (100%) | 37 (100%) | 1 |
| Anatomical success at month 6 after a single operation, n (%) | 34 (92%) | 33 (89%) | 0.7 |
| BCVA change at month 6, mean ± SD, logMAR | −0.71 ± 0.96 | −0.67 ± 1.01 | 0.9 |
| C3F8 gas tamponade, n (%) | 30 (81%) | 28 (76%) | 0.6 |
| Silicone oil tamponade, n (%) | 7 (19%) | 9 (24%) | 0.6 |
| Sutured sclerotomies, n (%) | 11 (29%) | 3 (8%) | 0.017 |
| Hypotony (IOP < 10 mmHg), n (%) | 2 (5%) | 0 (0%) | 0.5 |
| Severe IOP increase (>30 mmHg), n (%) | 5 (14%) | 4 (11%) | 0.7 |
SD: standard deviation; BCVA: best-corrected visual acuity; C3F8: perfluoropropane; IOP: intraocular pressure; logMAR: logarithm of the minimum angle of resolution; n: number; PPV: pars plana vitrectomy.